Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease

Summary

The primary purpose of this study is to assess the safety and optimal delivery of the Neo-Kidney Augment (NKA) when implanted at one site in a recipient kidney. NKA is made from expanded autologous, homologous, selected renal cells (SRC) obtained from the patient's kidney biopsy.

Timeline

Start

2013-04

Primary completion

2014-12

Completion

2014-12

Outcome

Outcome not reported

Stopped (Business): “lack of funding”

Drugs

Indications